Evidence map›Paper›PMID 25789166›Full record

ReviewBiomarker research2014

Nephrin - a biomarker of early glomerular injury.

Yogavijayan Kandasamy, Roger Smith, Eugenie R Lumbers, Donna Rudd

Open access · goldAbstract readReview
In one paragraph

Review in Biomarker research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Glucagon receptor agonist aggravates a murine model of Balkan nephropathy.American journal of physiology. Renal physiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Urinary biomarkers of diabetic kidney disease.World journal of diabetes · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Urinary Nephrin Concentrations in Preeclampsia (with and without Complications) vs Normal Pregnancies.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yogavijayan KandasamyDepartment of Neonatology, The Townsville Hospital, 100 Angus Smith Drive, Douglas, QLD 4814 Australia ; Hunter Medical Research Institute, Mothers and Babies Research Centre, John Hunter Hospital, The University of Newcastle, Callaghan, NSW 2310 Australia ; College of Public Health, Medical and Veterinary Sciences, The James Cook University, Townsville, QLD 4814 Australia.
Roger SmithHunter Medical Research Institute, Mothers and Babies Research Centre, John Hunter Hospital, The University of Newcastle, Callaghan, NSW 2310 Australia.
Eugenie R LumbersHunter Medical Research Institute, Mothers and Babies Research Centre, John Hunter Hospital, The University of Newcastle, Callaghan, NSW 2310 Australia.
Donna RuddCollege of Public Health, Medical and Veterinary Sciences, The James Cook University, Townsville, QLD 4814 Australia.
John Hunter Hospital · AUJames Cook University · AUTownsville Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrin is a 180 KD trans-membrane protein expressed in glomerular podocytes. It was first identified in children with congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrin forms an integral part of podocytes, which-together with endothelial cells and the basement-form the glomerular filtration barrier. Podocytopathies result in the detection of nephrin in the urine. We reviewed the literature to determine if urine nephrin measurements could become useful as a biomarker to detect early podocyte injury. Our search identified a total of 19 studies that have been published to date. The most common clinical conditions for which urine nephrin analyses were carried out included diabetic nephropathy, glomerulonephritis and pre-eclampsia. Nephrin measurement was carried out using commercially available ELISA kits, the messenger ribonucleic acid real-time polymerase chain Reaction, or electrophoresis. Nephrinuria showed positive correlation with proteinuria and severity of podocyte injury. In two studies, the level of nephrinuria declined in conjunction with clinical improvement in the patient following immunosuppressive treatment. Currently, there is no published data on the value of measuring urinary nephrin in pediatric patients.

Indexed as

BiomarkerGlomerular injuryNephrinNephrinuriaPodocytopathy

Identifiers

PMID25789166
PMCPMC4363192
OpenAlexW2167322296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.